2020 annual financial data

Coherus Oncology 2020 Operating margin

Coherus Oncology 2020 operating margin with verified reported values.

Direct answer

Operating margin was 32.85%.

Operating income was 156,319,000 USD and net income was 132,244,000 USD.
Operating cash flow was 154,145,000 USD.

Get free Coherus Oncology email updates.

Bullstory sends one daily email when new analysis or important company news is available.

Verified data

Revenue
475,824,000 USD
Operating income
156,319,000 USD
Net income
132,244,000 USD
Operating cash flow
154,145,000 USD